SCHEMBL7474710

SCHEMBL7474710

COc1cc(C(=O)Nc2ccc(C)cc2OCCCCCN2C(=O)c3ccccc3C2=O)ccc1[N+](=O)[O-]

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.54
POLB P06746 2/20 0.54
LMNA P02545 2/20 0.52
AGTR1 P30556 1/20 0.52
AKR1C3 P42330 1/20 0.48
AKR1C2 P52895 1/20 0.48
AKR1C1 Q04828 1/20 0.48
MYC P01106 4/20 0.48
MAX P61244 3/20 0.48
AR P10275 1/20 0.47
PELP1 Q8IZL8 1/20 0.47
RAB9A P51151 2/20 0.46
KMT2A Q03164 2/20 0.45
MEN1 O00255 1/20 0.45
MAPT P10636 2/20 0.45
MAPK1 P28482 1/20 0.45
EP300 Q09472 1/20 0.45
HIF1A Q16665 1/20 0.45
ABCB1 P08183 1/20 0.45
NPC1 O15118 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7430233 0.86 ALDH1A1 (0.58) ALDH1A1POLBRAB9AKMT2AMEN1
SCHEMBL7480971 0.83 ALDH1A1 (0.51) ALDH1A1POLBLMNAAGTR1RAB9A
SCHEMBL7376464 0.81 MYC (0.52) ALDH1A1LMNAAKR1C3AKR1C2AKR1C1
SCHEMBL7373903 0.80 ALDH1A1 (0.52) ALDH1A1POLBLMNAAGTR1RAB9A
SCHEMBL7342694 0.79 MYC (0.68) ALDH1A1AKR1C3AKR1C2AKR1C1MYC
SCHEMBL7426873 0.79 POLB (0.44) ALDH1A1POLBLMNAAGTR1AKR1C3
SCHEMBL7343440 0.76 MAPT (0.49) ALDH1A1POLBLMNAAKR1C3AKR1C2
SCHEMBL7337537 0.75 AR (0.61) ALDH1A1LMNAAKR1C3AKR1C2AKR1C1
SCHEMBL7372078 0.75 AR (0.58) ALDH1A1LMNAMYCMAXAR
SCHEMBL25039190 0.75 RAB9A (0.54) ALDH1A1POLBLMNAAGTR1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6316482-B1 FOR THERAPY AND PROPHYLAXIS OF HYPERTENSION, HEART FAILURE, RENAL INSUFFICIENCY, EDEMA, ASCITES, VASOPRESSIN PARASECRETION SYNDROME, HEPATOCIRRHOSIS, HYPONATREMIA, HYPOKALEMIA, DIABETIC, CIRCULATION DISORDER, CEREBROVASCULAR DISEASE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-11-13 US disclosed
EP-0946519-A1 BENZAMIDE DERIVATIVES HAVING A VASOPRESSIN ANTAGONISTIC ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-10-06 EP disclosed
WO-1998024771-A1 BENZAMIDE DERIVATIVES HAVING A VASOPRESSIN ANTAGONISTIC ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-06-11 WO disclosed